Skip to main content

Canadians thirsty for Canopy Growth Corp.’s cannabis-infused drinks will have to wait a bit longer.

The Smiths Falls, Ont.-based company said Friday that the debut of its cannabis drinks will now be delayed because it requires more time to develop its beverage facility and “the scaling process is not complete.”

“In order to deliver products that meet our customer’s high standards we are electing to revise the launch date while we work through the final details,” Canopy chief executive David Klein said in a statement.

Story continues below advertisement

Canopy’s beverage business is expected to be a cornerstone for the company, which is behind the brands Tweed, Tokyo Smoke, Doja and Van der Pop. Canopy has said it is preparing to produce 13 cannabis-related beverages. The company has the backing of Constellation Brands Inc., a New York company which invested $5 billion in Canopy in 2019 and has a portfolio of brands including Corona beers, Robert Mondavi and Kim Crawford wines and premium spirits from SVEDKA Vodka and Casa Noble Tequila.

Canopy had expected to release its cannabis beverages in early January as part of Cannabis 2.0, where the country is allowing a second wave of products such as edibles, extracts and topicals to hit the market following the October 2018 legalization of cannabis in Canada

Cannabis-infused chocolates, cookies, soft chews, mints, tea and vapes were made available on the Ontario Cannabis Store’s website at 9 a.m. local time Thursday and were on sale the week before at physical retailers in the country.

Canopy did not say when it now intends to launch its beverages.

It submitted the final documentation for its beverage facility to Health Canada last June and received its license in late November.

The company’s statement said it does not believe the delay will have a material impact on its revenue for its 2020 financial year. It plans to provide an update on the beverages’ status when it releases its third-quarter results.

RBC Capital Markets analyst Douglas Miehm said in a note that he saw Canopy’s news in a “neutral light” and believes that engineering issues connected to the introduction of tetrahydrocannabinol – the psychoactive compound that gives users a high – emulsion syrup into other ingredients have “ultimately contributed to quality assurance shortfalls upon completion.”

Story continues below advertisement

“While the release is somewhat surprising, we do reaffirm our confidence in the company’s production capabilities and note that when it comes to beverages, Canopy remains ahead of the pack,” he said.

“In our view, the issues likely rest in translating the quality, taste, and consistency generated in a lab setting to large-scale commercial manufacturing.”

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies